Epigenomics of hormone-driven cancers
Dr. Clarissa Gerhäuser
Team Leader Epigenomics of hormone-driven Cancer
Major Research Direction
In the Epigenomics of hormone-driven cancers group, current projects focus on
- The role of 5-hydroxymethylation in cancer
- Profiling DNA hydroxy-/methylation and chromatin accessibility
- Epigenetic mechanisms in cancer and metastasis development, with a focus on breast and prostate cancer
- Developing biomarkers for endogenous endocrine resistance in breast cancer
- Characterizing the enhancer methylome in prostate cancer
- The pan-prostate cancer methylome landscape
- cfDNA and liquid biopsies for early cancer detection